SAB Biotherapeutics, Inc. Share Price
NASDAQ: SABS | Micro CapSAB Biotherapeutics, Inc. Stock Performance
Open $3.73 | Prev. Close $3.76 | Circuit Range N/A |
Day Range $3.71 - $3.86 | Year Range $1.90 - $5.12 | Volume 33,872 |
Average Traded $3.78 |
SAB Biotherapeutics, Inc. Share Price Today
As of 9 August 2026, SAB Biotherapeutics, Inc.'s share price is $3.83. The stock opened at $3.73, compared to its previous close of $3.76. During today's trading session, SAB Biotherapeutics, Inc.'s share price traded between $3.71 and $3.86, with an average price of $3.79. Over the past 52 weeks, the stock has recorded a high of $5.12 and a low of $1.90. In terms of performance, SAB Biotherapeutics, Inc.'s share price has declined by 6.33% over the last six months and is up 86.17% on a year-on-year basis.
SAB Biotherapeutics, Inc. Share Price Chart
SAB Biotherapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $74.06M | PE Ratio (TTM) 17.43 | Dividend Yield N/A |
EPS (TTM) $0.22 | Revenue (TTM) N/A | Return On Equity (TTM) 8.76% |
Profit Margin N/A | Debt to Equity 0.07 | Quarterly Earnings Growth YoY 539.11% |
SAB Biotherapeutics, Inc. Quarterly Profit & Loss
All figures in USD
SAB Biotherapeutics, Inc. Annual Profit & Loss
All figures in USD
About SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.
SAB Biotherapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $3.59 | $3.84 | +7.87% |
Jul 2026 | $3.90 | $3.56 | -8.72% |
Jun 2026 | $3.68 | $3.90 | +8.48% |
May 2026 | $3.73 | $3.60 | -3.62% |
Apr 2026 | $3.90 | $3.73 | -2.86% |
Mar 2026 | $3.98 | $3.84 | -6.20% |
Feb 2026 | $4.44 | $4.09 | -6.53% |
Jan 2026 | $3.77 | $4.38 | +17.43% |
Dec 2025 | $3.95 | $3.73 | -6.16% |
Nov 2025 | $3.19 | $3.98 | +22.31% |
Oct 2025 | $1.97 | $3.25 | +67.53% |
Sep 2025 | $2.10 | $1.94 | -5.83% |
SABS Share Price FAQs
What is SAB Biotherapeutics, Inc. share price today?
What is the 52 week high and 52 week low of SAB Biotherapeutics, Inc. stock?
What is SABS's market capitalisation today?
What is SABS's net income for the last quarter?
What is the 5 year returns of SABS?
What is the high & low stock price of SABS today?
Can I buy SABS shares in India?